Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Different diets and the risk of lung cancer: a large prospective multicenter study Yingxian Dong West China hospital of Sichuan University PLCO May 29, 2024 PLCO-1566
Positive associations between dietary-induced acid load and renal cancer incidence and mortality: results from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Linglong Peng The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO May 29, 2024 PLCO-1570
Predicting mortality risk using cardiac LDCT regions chen yingchi National Yang Ming Chiao Tung University NLST May 16, 2024 NLST-1255
Using foundation model for cardiovascular disease detection. Xiaofeng Yang Emory University NLST May 16, 2024 NLST-1249
Nodule risk assessment Scott Morris Maverix Medical NLST May 16, 2024 NLST-1252
Underlying risk of developing and dying from lung cancer Louise Henderson University of North Carolina at Chapel Hill NLST May 16, 2024 NLST-1248
To develop a prediction model for non-small cell lung cancer based on radiomics Yang Ruiyi China Medical University NLST May 16, 2024 NLST-1246
Research on the evolutionary algorithm of CT images and pathological images based on multiple time scales Lijing Sun Nanjing Tech University NLST May 16, 2024 NLST-1250
Comparing Non-Malignancy Rate Definitions Utilizing the NLST Cohort Christopher Caruso University of Pennsylvania NLST May 16, 2024 NLST-1245
Adherence to Lifelines Diet Score (LLDS) is associated with lower lung cancer risk in 98,459 participants: a large prospective study Haitao Gu The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO May 14, 2024 PLCO-1560
Leveraging Machine Learning for Gynecologic Cancer Diagnosis: Visual Question Answering Elham Dolatabadi York University PLCO May 14, 2024 PLCOI-1557
Interactions, mediating effects, and nonlinear effects of biological markers, genomics and environmental exposures on the occurrence and prognosis of various types of cancers Jiahui Lao Department of Clinical Epidemiology, Shengjing Hospital of China Medical University PLCO May 14, 2024 PLCO-1550
Validate Colon Cancer Model trained on synthetic data against PLCO dataset patient data Jeremy Howard Lucem Health, Inc. PLCO May 14, 2024 PLCO-1553
Biomarker-assisted Decision Rule for Risk Classification under a positive predictive value - constraint: Application to disease screening Yingqi Zhao Fred Hutchinson Cancer Center PLCO May 14, 2024 PLCO-1556
Heterogeneous treatment effect estimation using instrumental variable in time-to-event data Uri Shalit Technion - Israel Institute of Technology HIPB May 13, 2024 HIPB-13
Risk and Influencing Factors for Subsequent Primary Lung Cancer After Treatment of Breast Cancer Yingxian Dong West China hospital of Sichuan University PLCO Apr 29, 2024 PLCO-1549
Diet and risks of lung cancer Kanran Wang Chongqing University Cancer Hospital PLCO Apr 29, 2024 PLCO-1547
AI Modeling Project for Predicting Treatment Response in Non-Small Cell Lung Cancer Anna Gracia Colmenarejo Universidad Internacional de La Rioja PLCO Apr 29, 2024 PLCO-1542
How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? Jiana Karthikeyan Franconian International School PLCO Apr 29, 2024 PLCO-1543
A novel accuracy metric for general M-class classification when subclasses are involved Nan Nan State University of New York at Buffalo PLCO Apr 29, 2024 PLCO-1531